AYALA PHARMACEUTICALS INC (AYLA)
US05465V1089 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to AYLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is 2330.5% above the current price.
AYLA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about AYLA.
In the last month the buy percentage rose by 28 points. So the trust of analysts is improving.
AYLA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-31 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-10-20 | Roth Capital | Downgrade | Buy -> Sell |
| 2022-09-20 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-20 | Maxim Group | Initiate | Buy |
| 2021-12-20 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-30 | Jefferies | Upgrade | Hold -> Buy |
| 2021-08-17 | Oppenheimer | Maintains | Outperform |
| 2021-07-13 | Ladenburg Thalmann | Initiate | Buy |